AstraZeneca PLC: AZN (O): why‘s the risk-reward positively skewed?

Research evidence excerpt

AstraZeneca PLC: AZN (O): why‘s the risk-reward positively skewed?

nd should not rely on the material herein to make an investment decision. The result

of such act will not hold the entities noted herein liable for any loss thus incurred as the entities noted herein are not registered/

authorised/ licensed to deal with retail clients and will not enter into any contractual agreement/arrangement with retail clients.

This report is provided subject to the terms and conditions of any agreement that the clients may have entered into with the entities

noted herein. All research reports are disseminated on a simultaneous basis to eligible clients through electronic publication to

our client portal.

The information in this report was prepared by Bernstein solely for the internal business use of our clients. Clients may store,

display, analyze, reformat and print the information in this report for this limited use only. Clients may not copy, alter, create

derivative works, resell, reverse engineer, commercially exploit, share or distribute any part of the information contained herein

for any purpose without Bernstein’s express written consent. These restrictions include extracting data or using the content to

develop indices or other products. Further, you may not use this report, or any portion of this report, to train or finetune any third-

party machine learning or artificial intelligence system, or as a prompt or input into any such system. You also may not, without

Bernstein’s express written consent, do any of the foregoing in connection with your own internal machine learning or artificial

intelligence system.

Bernstein may use artificial intelligence tools in the preparation of its materials. Any such materials are reviewed by Bernstein’s